相关实验视频

Updated: Jun 23, 2025

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

代谢对话:在瘤微环境中调节化学抗原受体T细胞功能的调节者

Josquin Moraly^1,2, Taisuke Kondo¹, Mehdi Benzaoui^1,3

¹Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Molecular oncology

|June 26, 2024

概括

瘤透淋巴细胞 (TIL) 和仿真抗原受体 (CAR) T 细胞是强大的癌症疗法. 它们的有效性取决于新陈代谢,这会影响T细胞的功能和持续性,从而改善癌症治疗.

科学领域:

免疫学免疫学免疫学
代谢途径代谢途径
癌症免疫疗法癌症免疫疗法

背景情况:

瘤透淋巴细胞 (TIL) 和仿真抗原受体 (CAR) T 细胞在治疗黑色素瘤和血液性恶性瘤方面取得了重大进展.
这些活药的有效性取决于它们在患者中的增殖和持久性.
新兴研究强调了代谢转变在调节T细胞功能和分化中的关键作用.

研究的目的:

审查激活的T细胞的代谢重塑.
检查瘤的代谢微环境如何影响T细胞功能.
探索增强T细胞免疫疗法的代谢策略.

主要方法:

对T细胞代谢和癌症免疫治疗研究的文献综述.
分析影响T细胞增殖和持久性的代谢途径.
讨论营养的可用性和代谢物转运器的作用.

主要成果:

代谢重编程对于T细胞的激活,分化和功能至关重要.
瘤微环境带来代谢挑战,可能会影响T细胞活动.
代谢途径与信号和表观遗传修饰密切相关.

结论:

了解T细胞代谢是优化免疫治疗的关键.
代谢干预有望提高TIL和CAR T细胞疗法的疗效.
准代谢途径可以克服耐药性并增强抗瘤反应.

关键词:

在T细胞,T细胞.抗瘤免疫疗法免疫疗法仿制性抗原受体的复制性受体.免疫代谢的免疫代谢.营养物质的运输体是营养物质的运输体.瘤微环境是一个微环境.

更多相关视频

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...